Eric G Voog
Overview
Explore the profile of Eric G Voog including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bilen M, Rini B, Voss M, Larkin J, Haanen J, Albiges L, et al.
Clin Cancer Res
. 2021 Nov;
28(4):738-747.
PMID: 34789480
Purpose: To evaluate the association between neutrophil-to-lymphocyte ratio (NLR) and efficacy of avelumab plus axitinib or sunitinib. Experimental Design: Adult patients with untreated advanced renal cell carcinoma (RCC) with a...
2.
Bobin A, Kyheng M, Guidez S, Gruchet-Merouze C, Richez V, Duhamel A, et al.
Leukemia
. 2021 Oct;
36(3):881-884.
PMID: 34650225
No abstract available.
3.
Abida W, Campbell D, Patnaik A, Shapiro J, Sautois B, Vogelzang N, et al.
Clin Cancer Res
. 2020 Feb;
26(11):2487-2496.
PMID: 32086346
Purpose: Genomic alterations in DNA damage repair (DDR) genes other than may confer synthetic lethality with PARP inhibition in metastatic castration-resistant prostate cancer (mCRPC). To test this hypothesis, the phase...
4.
Leleu X, Fouquet G, Richez V, Guidez S, Duhamel A, Machuron F, et al.
Clin Cancer Res
. 2019 May;
25(14):4224-4230.
PMID: 31053600
Purpose: Carfilzomib is a novel generation proteasome inhibitor. The Carmysap trial demonstrated that twice-weekly KMP (carfilzomib, melphalan, prednisone) might challenge the MPV (melphalan, prednisone, bortezomib) standard. We sought to study...